Recent advances in the study of biomolecular condensates could help answer some of biology’s biggest questions.

At Dewpoint, we believe condensates are also the key to creating medicines for some of the toughest diseases.
Our Impact

The conventional view of biology and its limitations

For decades our understanding of cell biology has focused on two key aspects. The first is an obsession with membrane-bound organelles (such as mitochondria, lysosomes, and the endoplasmic reticulum) and their role in the organization of the key cellular functions. For example, the energy source of the cell is compartmentalized inside a mitochondrion.

Cajal bodiesBut this classical view has always been hard to reconcile with images that show cells to have large numbers of condensates that lack membranes and perform diverse functions. This 1903 drawing by Santiago Ramón y Cajal, for instance, depicts pyramidal neurons with visible Cajal bodies (a), nucleoli (b), and speckles (c). It has become increasingly clear in the last decade that a significant proportion of proteins and RNAs in a cell are located in distinct condensates, where they perform diverse functions.

The second assumption is that proteins, the machines of the cell, have well-defined and stable structures that perform their functions through changes in their conformation. However, these approaches have downplayed the 40 percent of the coding sequence that encodes segments of proteins called “intrinsically disordered regions” (IDRs). IDRs have been understudied, largely because their structures cannot easily be trapped by conventional techniques, such as crystallography, which have traditionally been used to characterize protein structure.

Human genetics studies are increasingly pointing to critical roles of these IDRs in disease, and parallel work coming from physical chemistry and cell biology has shown that IDRs are also essential for condensate formation. The fusion of these two fields is rewriting the rules of cell biology and disease.

A new approach to biology

“The real voyage of discovery consists, not in seeking new landscapes, but in having new eyes.” Marcel Proust

Starting with the study of P granules in C.elegans embryos in 2009, Tony Hyman, working with his collaborators like Frank Julicher, Cliff Brangwynne, Simon Alberti, Mike Rosen, and Rohit Pappu, began to unravel the mysteries of biomolecular condensates. These scientists realized that P granules behave like liquid droplets that form by phase separation (think of oil droplets in salad dressing) and called them condensates.

Biology, meet physics

The concept that cellular compartments are liquid-like and form by phase separation reaches back over a century ago…

Our Impact

Condensates play a critical role in important, once-intractable diseases. Dewpoint develops drugs that exploit this biology.

Starting with the study of stress granules and their role in ALS, researchers, including members of the Hyman Lab, began to connect biomolecular condensates to disease. Dewpoint now believes that a vast range of diseases have pathways that are regulated by condensates or arise from the dysfunction of condensates, in areas spanning cancer, neurodegeneration, cardiovascular disease, and metabolic disease. In addition, biomolecular condensates offer a new approach to “undruggable” target classes like transcription factors and phosphatases.

a video thumbnail

Phase transition and ALS


Contact us

Dewpoint is building proprietary tools for purposefully exploiting condensates to treat the most important diseases that patients face. If you would like to learn more about our platform please contact us.

Contact Us